Anil Karihaloo Novo NordiskUnited States

Ph.D in neuroscience from PGIMER , Chandigarh, IndiaPostdoc at University of Michigan and Harvard medical school.Research faculty at Yale University School of Medicine until 2014Joined AstraZeneca in 2014 and Novo Nordisk in 2017 to lead early target discovery efforts in CKD

1 APRIL 2023

Time Session
15:45
16:45
Wenjun Ju Chairperson wenjunj@med.umich.eduUniversity Of Michigan Medical CenterUnited States
Maria F. Gomez Chairperson maria.gomez@med.lu.seSweden
MR 109 CDHG